Tuesday 23rd March 2021
|Text too small?|
Pushpay Holdings Limited understands that interests associated with Christopher & Banks V Limited, the investment vehicle associated with Peter Huljich and Christopher Huljich, entered into agreements on 22 March 2021 with affiliates managed by Sixth Street, a leading global investment firm, under which that shareholder has sold 100% of their shares in Pushpay to Sixth Street.
Pushpay is pleased to welcome a new cornerstone investor as Sixth Street adds to its existing position in the Company. Pushpay understands that Sixth Street will become its largest shareholder, holding approximately 17.8% of the total number of Pushpay shares after the acquisition is completed on 30 March 2021.
Pushpay’s Chairman, Graham Shaw said, “We are delighted to welcome Sixth Street as a cornerstone investor in Pushpay. As a highly experienced technology and growth investor with a core thematic focus on the convergence of software and payments, Sixth Street’s global scale and partnership-oriented investing approach brings considerable strength to Pushpay’s shareholder register.
“On behalf of Pushpay, I would also like to sincerely thank Peter and Christopher Huljich for their invaluable contribution and commitment to the business over the past seven years. We are extremely grateful for their support and wish them all the best with their future endeavours.”
Sixth Street is a global investment firm with over US$50 billion in assets under management and committed capital. Founded in 2009, the firm has more than 320 team members including over 145 investment professionals operating from nine locations around the world.
Please see the link below for details:
No comments yet
Meridian Energy monthly operating report for July 2022
Cannasouth to launch a pro-rata renounceable rights issue
August 12th Morning Report
2022 Annual Shareholders' Meeting & Director Nominations
Rakon 2022 Annual Meeting Chair's Address and Presentation
VHP - Full year results release
RAKON FY23 Earnings Guidance
August 11th Morning Report
Deferral of FDA consideration of enforcement discretion
MHJ - Response to ASX Query